Kinase impact assessment in the landscape of fusion genes that retain kinase domains: a pan-cancer study

Assessing the impact of kinase in gene fusion is essential for both identifying driver fusion genes (FGs) and developing molecular targeted therapies. Kinase domain retention is a crucial factor in kinase fusion genes (KFGs), but such a systematic investigation has not been done yet. To this end, we analyzed kinase domain retention (KDR) status in chimeric protein sequences of 914 KFGs covering 312 kinases across 13 major cancer types. Based on 171 kinase domain-retained KFGs including 101 kinases, we studied their recurrence, kinase groups, fusion partners, exon-based expression depth, short DNA motifs around the break points and networks. Our results, such as more KDR than 5'-kinase fusion genes, combinatorial effects between 3'-KDR kinases and their 5'-partners and a signal transduction-specific DNA sequence motif in the break point intronic sequences, supported positive selection on 3'-kinase fusion genes in cancer. We introduced a degree-of-frequency (DoF) score to measure the possible number of KFGs of a kinase. Interestingly, kinases with high DoF scores tended to undergo strong gene expression alteration at the break points. Furthermore, our KDR gene fusion network analysis revealed six of the seven kinases with the highest DoF scores (ALK, BRAF, MET, NTRK1, NTRK3 and RET) were all observed in thyroid carcinoma. Finally, we summarized common features of 'effective' (highly recurrent) kinases in gene fusions such as expression alteration at break point, redundant usage in multiple cancer types and 3'-location tendency. Collectively, our findings are useful for prioritizing driver kinases and FGs and provided insights into KFGs' clinical implications.

[1]  Aleksandar Milosavljevic,et al.  Identification of cancer fusion drivers using network fusion centrality , 2013, Bioinform..

[2]  B. Falini,et al.  Nucleophosmin-anaplastic lymphoma kinase (NPM-ALK), a novel Hsp90-client tyrosine kinase: down-regulation of NPM-ALK expression and tyrosine phosphorylation in ALK(+) CD30(+) lymphoma cells by the Hsp90 antagonist 17-allylamino,17-demethoxygeldanamycin. , 2002, Cancer research.

[3]  John D. Hunter,et al.  Matplotlib: A 2D Graphics Environment , 2007, Computing in Science & Engineering.

[4]  D. Brat,et al.  Transforming Fusions of FGFR and TACC Genes in Human Glioblastoma , 2012, Science.

[5]  Angelo Rosolen,et al.  Ubiquitination and proteasomal degradation of nucleophosmin-anaplastic lymphoma kinase induced by 17-allylamino-demethoxygeldanamycin: role of the co-chaperone carboxyl heat shock protein 70-interacting protein. , 2004, Cancer research.

[6]  O. Witte,et al.  Clinical Targeting of Mutated and Wild-Type Protein Tyrosine Kinases in Cancer , 2014, Molecular and Cellular Biology.

[7]  Peng Qiu,et al.  TCGA-Assembler: open-source software for retrieving and processing TCGA data , 2014, Nature Methods.

[8]  Alfonso Valencia,et al.  Novel domain combinations in proteins encoded by chimeric transcripts , 2012, Bioinform..

[9]  Tatiana Tatusova,et al.  NCBI Reference Sequence (RefSeq): a curated non-redundant sequence database of genomes, transcripts and proteins , 2004, Nucleic Acids Res..

[10]  M. Ashburner,et al.  Gene Ontology: tool for the unification of biology , 2000, Nature Genetics.

[11]  A. Whitmarsh Regulation of gene transcription by mitogen-activated protein kinase signaling pathways. , 2007, Biochimica et biophysica acta.

[12]  P. Wiffen,et al.  Interventions for fatigue and weight loss in adults with advanced progressive illness. , 2017, The Cochrane database of systematic reviews.

[13]  M. Bodén,et al.  Associating transcription factor-binding site motifs with target GO terms and target genes , 2008, Nucleic acids research.

[14]  Nicolas Stransky,et al.  The landscape of kinase fusions in cancer , 2014, Nature Communications.

[15]  Mikael Bodén,et al.  MEME Suite: tools for motif discovery and searching , 2009, Nucleic Acids Res..

[16]  J. Parsons,et al.  pp125FAK a structurally distinctive protein-tyrosine kinase associated with focal adhesions. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[17]  Pornpimol Charoentong,et al.  ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks , 2009, Bioinform..

[18]  Wen-chang Lin,et al.  Vir-Mir db: prediction of viral microRNA candidate hairpins , 2007, Nucleic Acids Res..

[19]  B. Fraile,et al.  MAP Kinases and Prostate Cancer , 2011, Journal of signal transduction.

[20]  Arul M. Chinnaiyan,et al.  Landscape of gene fusions in epithelial cancers: seq and ye shall find , 2015, Genome Medicine.

[21]  John N. Weinstein,et al.  PRADA: pipeline for RNA sequencing data analysis , 2014, Bioinform..

[22]  Brian T. Lee,et al.  The UCSC Genome Browser database: 2015 update , 2014, Nucleic Acids Res..

[23]  S. Bohlander Fusion genes in leukemia: an emerging network , 2001, Cytogenetic and Genome Research.

[24]  M. Babu,et al.  Discovering and understanding oncogenic gene fusions through data intensive computational approaches , 2016, Nucleic acids research.

[25]  Mikhail Shugay,et al.  Oncofuse: a computational framework for the prediction of the oncogenic potential of gene fusions , 2013, Bioinform..

[26]  Kai Wang,et al.  The distribution of BRAF gene fusions in solid tumors and response to targeted therapy , 2015, International journal of cancer.

[27]  J. Tchinda,et al.  Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. , 2006, Science.

[28]  Chris Wiggins,et al.  Pegasus: a comprehensive annotation and prediction tool for detection of driver gene fusions in cancer , 2014, BMC Systems Biology.

[29]  Jiandong Shi,et al.  Identification and validation of a novel microRNA-like molecule derived from a cytoplasmic RNA virus antigenome by bioinformatics and experimental approaches , 2014, Virology Journal.

[30]  Joshua M. Stuart,et al.  The Cancer Genome Atlas Pan-Cancer analysis project , 2013, Nature Genetics.

[31]  Mikael Bodén,et al.  Assigning roles to DNA regulatory motifs using comparative genomics , 2010, Bioinform..

[32]  Jing Wang,et al.  WEB-based GEne SeT AnaLysis Toolkit (WebGestalt): update 2013 , 2013, Nucleic Acids Res..

[33]  P. Pinton,et al.  Protein Kinases and Phosphatases in the Control of Cell Fate , 2011, Enzyme research.

[34]  R. Verhaak,et al.  The landscape and therapeutic relevance of cancer-associated transcript fusions , 2014, Oncogene.

[35]  Xin Li,et al.  Short Homologous Sequences Are Strongly Associated with the Generation of Chimeric RNAs in Eukaryotes , 2008, Journal of Molecular Evolution.

[36]  V. Radha,et al.  Association of Lyn tyrosine kinase with the nuclear matrix and cell-cycle-dependent changes in matrix-associated tyrosine kinase activity. , 1996, European journal of biochemistry.

[37]  Zhongming Zhao,et al.  mutLBSgeneDB: mutated ligand binding site gene DataBase , 2016, Nucleic Acids Res..

[38]  M. Höglund,et al.  A gene fusion network in human neoplasia , 2006, Oncogene.

[39]  Tony Hunter,et al.  Treatment for chronic myelogenous leukemia: the long road to imatinib. , 2007, The Journal of clinical investigation.

[40]  Mingming Jia,et al.  COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer , 2010, Nucleic Acids Res..

[41]  B. Druker Inhibition of the Bcr-Abl tyrosine kinase as a therapeutic strategy for CML , 2002, Oncogene.

[42]  Sanghyuk Lee,et al.  ChimerDB 2.0—a knowledgebase for fusion genes updated , 2009, Nucleic Acids Res..

[43]  P. Shannon,et al.  Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.

[44]  T. Jacks,et al.  The cell cycle and cancer. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[45]  C. Thiemermann,et al.  Effects of tyrphostins and genistein on the circulatory failure and organ dysfunction caused by endotoxin in the rat: a possible role for protein tyrosine kinase , 1997, British journal of pharmacology.

[46]  J. Demoulin,et al.  Tyrosine kinase gene fusions in cancer: translating mechanisms into targeted therapies , 2012, Journal of cellular and molecular medicine.

[47]  B. Johansson,et al.  The emerging complexity of gene fusions in cancer , 2015, Nature Reviews Cancer.

[48]  Yuri E Nikiforov,et al.  Thyroid carcinoma: molecular pathways and therapeutic targets , 2008, Modern Pathology.

[49]  F. Tsukahara,et al.  Bag1 directly routes immature BCR-ABL for proteasomal degradation. , 2010, Blood.

[50]  O. Witte,et al.  The BCR-ABL story: bench to bedside and back. , 2004, Annual review of immunology.

[51]  T. Hunter,et al.  The Protein Kinase Complement of the Human Genome , 2002, Science.

[52]  Peer Bork,et al.  OGEE: an online gene essentiality database , 2011, Nucleic Acids Res..

[53]  E. Grande,et al.  Targeting Oncogenic ALK: A Promising Strategy for Cancer Treatment , 2011, Molecular Cancer Therapeutics.

[54]  Zhongming Zhao,et al.  Targeted next-generation sequencing of DNA regions proximal to a conserved GXGXXG signaling motif enables systematic discovery of tyrosine kinase fusions in cancer , 2010, Nucleic acids research.

[55]  C. Pecqueur,et al.  Targeting Metabolism to Induce Cell Death in Cancer Cells and Cancer Stem Cells , 2013, International journal of cell biology.

[56]  B. Johansson,et al.  Fusion genes and rearranged genes as a linear function of chromosome aberrations in cancer , 2004, Nature Genetics.

[57]  H. Aburatani,et al.  Identification of the transforming EML4–ALK fusion gene in non-small-cell lung cancer , 2007, Nature.

[58]  R. Salgia Role of c-Met in cancer: emphasis on lung cancer. , 2009, Seminars in oncology.

[59]  Qingguo Wang,et al.  Application of next generation sequencing to human gene fusion detection: computational tools, features and perspectives , 2013, Briefings Bioinform..

[60]  E. V. Van Allen,et al.  Clinical analysis and interpretation of cancer genome data. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[61]  Michele Magrane,et al.  UniProt Knowledgebase: a hub of integrated protein data , 2011, Database J. Biol. Databases Curation.